European Molecular Biology Laboratory
60
MENTIONS
8
EPISODES
6
PODCASTS
Search complete. 60 mentions across 8 episodes found for "European Molecular Biology Laboratory".
Nov 6, 2026
44. Gareth Griffiths - EMBL in the 1970s and early advancements in Electron Microscopy techniques
A
0:00Angus LamondHOST
Welcome to the EMBL Alumni Chats podcast sponsored by EMBLEm Technology Transfer.
T
0:06Thomas VaccariNARRATOR
In this episode, former EMBL group leader Gareth Griffiths speaks about his decades-long career in cell biology, his experiences at the forefront of electron microscopy advancements at EMBL, and his concerns about the decline in usage of this technique.
T
0:24Thomas VaccariNARRATOR
This interview is conducted by former EMBL group leader Angus Lamond.
T
0:28Thomas VaccariNARRATOR
It was recorded in April 2024.
T
0:32Thomas VaccariNARRATOR
So what was
A
0:33Angus LamondHOST
the EMBL like back in the 1970s? What was the cell biology department like?
G
0:39Gareth GriffithsGUEST
Well, the whole place was wild.
G
0:41Gareth GriffithsGUEST
There were about 50 people then, altogether then.
[EN] ByteSized: Green(er) Continuous Integration/Deployment - Joe Wallwork
P
2:47Peter SchmidtHOST
This special interest group, SICK for short, has been quite busy since the launch two years ago, which brings me to this bite-sized session.
P
2:56Peter SchmidtHOST
Because together with the European Molecular Biology Laboratory and its European Bioinformatics Institute, the short version of which is EMBL-EBI, they organise a series of online courses this autumn.
P
3:09Peter SchmidtHOST
all around green computing.
P
3:12Peter SchmidtHOST
In four sessions, they'll touch on the various aspects of green computing and I will come back to all of that at the end of this episode.
US Voters Pass About 38 of 44 Limits on AI Data Centers
B
9:33Ben LinfordHOST
But those variations turn out to actually follow rules.
B
9:37Ben LinfordHOST
The teams who studied this came from EMBL, which is the German Cancer Research Center, and the Wellcome Sanger Institute.
B
9:43Ben LinfordHOST
They found the same spatial arrangement of cell states in tumors from 12 different patients.
B
9:50Ben LinfordHOST
They then worked with a deep learning framework called SCDORI, which traces the regulators steering those switches across more than a million patient-derived cells.
Ep. 123 - Gilde’s Joep Muijrers on why patients belong in the investment process
S
1:05Stephen HansenHOST
Prior to Gilda, he was CFO and Chief of Portfolio Strategy for the biotech company PureTech Health, and before that, also spent 12 years as Partner and Portfolio Manager at LSP, investing in public biotechs.
S
1:21Stephen HansenHOST
Joep holds a PhD in molecular biology from the European Molecular Biology Laboratory and a master's in biochemistry from the University of Nijmegen.
S
1:31Stephen HansenHOST
Joep, I've got two things for you.
S
1:33Stephen HansenHOST
First, welcome to the Biocentury Show.
42. Frank Gannon - Early days of recombinant DNA technology and protecting research funding during the financial crisis
S
0:36speaker_0NARRATOR
It was recorded in April 2024.
F
0:39Frank GannonGUEST
First of all, I'm Frank Gannon and I was the director of EMBO, but also significantly I was at various stages, I think the scientific director of EMBL was the first thing and then it became senior scientists and various roles in EMBL that I'll come to later on.
F
0:57Frank GannonGUEST
But how I got here with circuitous.
F
1:01Frank GannonGUEST
I did my PhD in England, postdoc in America, postdoc and position in Strasbourg in France.
F
3:10Frank GannonGUEST
They gave me the job and I was nervous because EMBO was a huge, well-organised, big organisation, huge reputation.
F
3:22Frank GannonGUEST
I'd been an EMBO member and proud to be one.
F
3:26Frank GannonGUEST
And EMBL was even a larger laboratory at a scale and quality that was unsurpassed.
F
3:32Frank GannonGUEST
So coming in as in a key position in that world had me slightly concerned.
The Life Scientific: Edith Heard
J
21:03Jim Al-KhaliliHOST
Well, this obviously helped further your reputation.
J
21:06Jim Al-KhaliliHOST
And in 2019, you accepted the role of Director General of the prestigious European Molecular Biology Laboratory, known as EMBL or EMBL.
J
21:17Jim Al-KhaliliHOST
I know you were enjoying your lab work.
J
21:18Jim Al-KhaliliHOST
So did you have any qualms about taking on this new and quite different role?
E
21:24Edith HeardGUEST
I kind of realised that maybe it would be useful for someone like me, a scientist who had had a very active and successful career, to take on a bigger role in an organisation that was designed to try and help support European science as a whole.
E
21:44Edith HeardGUEST
And so when I started at EMBL, I was asked to come up with a whole new program accelerating into research areas that no other institute alone could do.
E
21:57Edith HeardGUEST
EMBL being funded by 27 at the time, now 30 member states, it needed to do something that was ahead of the game.
E
22:05Edith HeardGUEST
So we came up with a program that was called Molecules to Ecosystems.
From Tumor Immunology to Precision Oncology: Bispecific Antibodies, Liquid Biopsy & Translational Research | Dr. Karsten Michael Warwas
K
8:09Karsten Michael WarwasGUEST
Yeah, where to start? So I think Heidelberg is, I would say, quite a unique place, especially for oncology, because we have all those research institutions.
K
8:22Karsten Michael WarwasGUEST
We have the EMBL, which is the European Molecular, what's it called? Uh, I don't know really the abbreviation, but, uh, you know, like, for for molecular science, we have that, um, institute and of course, the German cancer research center, which is, uh, quite big and focus on cancer.
K
8:42Karsten Michael WarwasGUEST
Um, then here at the national center for tumor disease density, um, we have to focus on on, uh, research and translational research.
K
8:50Karsten Michael WarwasGUEST
So.
40. David States - Documenting EMBL's early history and personalising science for the general public
T
0:00Thomas VaccariHOST
Welcome to the EMBL Alumni Chats podcast, sponsored by EMBL Technology Transfer.
T
0:07Thomas VaccariHOST
In this episode, EMBL's very first communications officer, David States, discusses his project of documenting EMBL's 20-year history in 1994.
T
0:18Thomas VaccariHOST
David also speaks on the significance of clear and persuasive communication in science, emphasizing the need for scientists to convey their ideas to non-experts.
T
0:30Thomas VaccariHOST
This interview was conducted by former EMBL group leader Angus Lamond, and it was recorded in March 2024.
D
0:37David StatesGUEST
My name's David States.
D
0:38David StatesGUEST
I was at, uh, EMBL from, I believe, '93 to '96, '97, sometime around there.
D
0:47David StatesGUEST
Um, I live in, uh, Santa Cruz, California, and have done so for the last 20 years since I left Heidelberg.
A
0:55Angus LamondHOST
David, it's great to see you again.